We touch the lives of people living with Parkinson’s disease in many ways. From innovative therapies, like CREXONT ®, ONGENTYS ®, and RYTARY ®, to research, education initiatives, and community engagement, we bring hope and support to patients and their families.
Our broad portfolio of approximately 280+ generic and specialty pharmaceuticals is the foundation from which we make healthy possible. And we expanded our portfolios to institutions, in biosimilars and across select international markets.
